Remus Barbara S, Goldgur Yehuda, Shuman Stewart
Molecular Biology Program, Sloan-Kettering Institute, New York, NY 10065, USA.
Structural Biology Program, Sloan-Kettering Institute, New York, NY 10065, USA.
Nucleic Acids Res. 2017 Dec 15;45(22):12945-12953. doi: 10.1093/nar/gkx1159.
Fungal tRNA ligase (Trl1) is an essential enzyme that repairs RNA breaks with 2',3'-cyclic-PO4 and 5'-OH ends inflicted during tRNA splicing and non-canonical mRNA splicing in the fungal unfolded protein response. Trl1 is composed of C-terminal cyclic phosphodiesterase and central polynucleotide kinase domains that heal the broken ends to generate the 3'-OH,2'-PO4 and 5'-PO4 termini required for sealing by an N-terminal ligase domain. Trl1 enzymes are found in all human fungal pathogens and are promising targets for antifungal drug discovery because their domain compositions and biochemical mechanisms are unique compared to the mammalian RtcB-type tRNA splicing enzyme. A distinctive feature of Trl1 is its preferential use of GTP as phosphate donor for the RNA kinase reaction. Here we report the 2.2 Å crystal structure of the kinase domain of Trl1 from the fungal pathogen Candida albicans with GDP and Mg2+ in the active site. The P-loop phosphotransferase fold of the kinase is embellished by a unique 'G-loop' element that accounts for guanine nucleotide specificity. Mutations of amino acids that contact the guanine nucleobase efface kinase activity in vitro and Trl1 function in vivo. Our findings fortify the case for the Trl1 kinase as an antifungal target.
真菌tRNA连接酶(Trl1)是一种必需酶,可修复在真菌未折叠蛋白反应中的tRNA剪接和非经典mRNA剪接过程中产生的具有2',3'-环磷酸和5'-羟基末端的RNA断裂。Trl1由C端环磷酸二酯酶和中央多核苷酸激酶结构域组成,这些结构域修复断裂末端,以产生N端连接酶结构域进行封闭所需的3'-羟基、2'-磷酸和5'-磷酸末端。Trl1酶存在于所有人类真菌病原体中,由于其结构域组成和生化机制与哺乳动物RtcB型tRNA剪接酶相比具有独特性,因此是抗真菌药物发现的有前景的靶点。Trl1的一个显著特征是其在RNA激酶反应中优先使用GTP作为磷酸供体。在这里,我们报道了来自真菌病原体白色念珠菌的Trl1激酶结构域在活性位点含有GDP和Mg2+的2.2 Å晶体结构。激酶的P环磷酸转移酶折叠由一个独特的“G环”元件修饰,该元件决定了鸟嘌呤核苷酸特异性。与鸟嘌呤碱基接触的氨基酸突变在体外消除激酶活性,并在体内消除Trl1功能。我们的发现强化了将Trl1激酶作为抗真菌靶点的理由。